ABBV's oncology lineup, spanning blood and solid tumor drugs, faces modest Q3 growth as new launches offset Imbruvica's ...
AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company's previous bestseller Humira in a ...
In Q3, the top 10 TV ad spenders poured a combined $544.8 million into airing their commercials, according to data shared ...
The insurer, which is the parent company for Harvard Pilgrim Health Care and Tufts Health Plan, said the reductions represent ...
The Polaris Global Equity Composite gained 5.04% (net of fees) for the quarter, while the MSCI World Index returned 7.36%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback